InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-12.5%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Feinberg David T, 董事长兼首席执行官. Director active across 4 companies, notably CERNER Corp. In total, 7 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €510k. Activity tracked since 29 December 2021. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Feinberg David T
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
766 股0Humana CommonSEC:0001486426-26-000002:0
3,528 股0Common StockSEC:0001225208-25-004950:0
2,308 股0Common StockSEC:0001225208-24-007394:0
441 股0Humana CommonSEC:0001062993-23-005726:0
25,000 股@ US$20.31100.0% 占其流量Common StockSEC:0000895345-22-000672:0
标准退出：2022年12月1日 (T+90)
31,319 股@ US$95.00100.0% 占其流量Common StockSEC:0001209191-22-035495:0
7,374 股0Common StockSEC:0001209191-21-071600:0
7 条申报中的 7 条
About Feinberg David T
Feinberg David T is Président-Directeur Général and has 7 filings in total. Among the sampled recent filings from 2021-12-30 to 2026-01-05, the modal transaction nature is Attribution, with EUR 510182 of buys and EUR 0 of sells, and the companies cited are HUMANA INC, Edwards Lifesciences Corp, CERNER Corp and Douglas Emmett Inc.
